A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors

被引：0
|
作者：
Jonathan Metts
Brittany Harrington
Emad Salman
Scott M. Bradfield
Jennifer Flanary
Maua Mosha
Ernest Amankwah
Stacie Stapleton
机构：
[1] Johns Hopkins All Children’s Hospital,Cancer and Blood Disorders Institute
[2] Hospital Medicine,Division of Pediatric Hematology/Oncology
[3] MyMichigan Health,Data Coordinating Center for Pediatric Multicenter Studies
[4] Golisano Children’s Hospital of Southwest Florida,Department of Oncology
[5] Nemours Children’s Health,undefined
[6] Institute for Clinical and Translational Research,undefined
[7] Johns Hopkins All Children’s Hospital,undefined
[8] Johns Hopkins University School of Medicine,undefined
来源：
Child's Nervous System | 2022年 / 38卷
关键词：
Phase I; Pediatric; Brain tumor; Irinotecan; Temozolomide; Bevacizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：919 / 928
页数：9
相关论文
共 50 条
  • [41] Phase I trial and pharmacokinetic study of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with refractory solid tumors: A Children's Oncology Group Phase I Consortium study
    Wagner, L. M.
    Perentesis, J. P.
    Reid, J. M.
    Ames, M. M.
    Safgren, S. L.
    Nelson, M. D.
    Ingle, A. M.
    Blaney, S. M.
    Adamson, P. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent/refractory malignant posterior fossa tumors of the central nervous system
    Khatua, Soumen
    Lee, Dean
    Cooper, Laurence
    Moyes, Judy
    Sandberg, David
    Sadighi, Zsila
    Meador, Heather
    Ketonen, Leena
    Rytting, Michael E.
    Johnson, Jason M.
    Raagonanan, Dristhi
    Liu, Diane D.
    Gopalakrishnan, Vidya
    Zaky, Wafik
    CANCER RESEARCH, 2019, 79 (13)
  • [43] PHASE I STUDY OF INTRAVENTRICULAR INFUSIONS OF AUTOLOGOUS EX VIVO EXPANDED NK CELLS IN CHILDREN WITH RECURRENT/REFRACTORY MALIGNANT POSTERIOR FOSSA TUMORS OF THE CENTRAL NERVOUS SYSTEM
    Khatua, Soumen
    Gopalakrishnan, Vidya
    Sandberg, David
    Ketonen, Leena
    Johnson, Jason
    Cooper, Laurence
    Moyes, Judy
    Lee, Dean
    Meador, Heather
    Rytting, Michael
    Liu, Diane
    Zaky, Wafik
    NEURO-ONCOLOGY, 2018, 20 : 67 - 68
  • [44] A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumors.
    Casanova, Michela
    Kramm, Christof
    Reinhardt, Dirk
    Locatelli, Franco
    D'Adamo, David R.
    Scott, Rachael
    Jia, Yan
    Aluri, Jagadeesh
    Favre, Claudio
    Bautista, Francisco
    Alvaro, Raquel Hladun
    Urgelles, Ana Sastre
    Kontny, Udo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] A phase I study of irinotecan in combination with metronomic temozolomide in patients with recurrent glioblastoma
    Reynes, Gaspar
    Balana, Carmen
    Gallego, Oscar
    Iglesias, Luis
    Perez, Pedro
    Garcia, Jose L.
    ANTI-CANCER DRUGS, 2014, 25 (06) : 717 - 722
  • [46] Phase I Trial of Two Schedules of Vincristine, Oral Irinotecan, and Temozolomide (VOIT) for Children With Relapsed or Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Study
    Wagner, Lars M.
    Perentesis, John P.
    Reid, Joel M.
    Ames, Matthew M.
    Safgren, Stephanie L.
    Nelson, Marvin D., Jr.
    Ingle, Ashish M.
    Blaney, Susan M.
    Adamson, Peter C.
    PEDIATRIC BLOOD & CANCER, 2010, 54 (04) : 538 - 545
  • [47] Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
    Murakami, Mineko
    Fujimaki, Takamitsu
    Asano, Shuichiro
    Nakaguchi, Hiroshi
    Yamada, Shoko M.
    Hoya, Katsumi
    Yamazaki, Kazuto
    Ishida, Yasuo
    Matsuno, Akira
    YONSEI MEDICAL JOURNAL, 2011, 52 (06) : 1031 - 1034
  • [48] PHASE I/IB STUDY OF LONAFARNIB AND TEMOZOLOMIDE IN PATIENTS WITH RECURRENT OR TEMOZOLOMIDE REFRACTORY GLIOBLASTOMA
    Yust-Katz, Shlomit
    Liu, Vivian
    Sanghee, Kang
    Groves, Moriss
    Puduvalli, Vinay
    Levin, Victor
    Conrad, Charles
    Colman, Howard
    Hsu, Sigmund
    Yung, Alfred W.
    Gilbert, Mark R.
    NEURO-ONCOLOGY, 2012, 14 : 68 - 68
  • [49] A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors
    Fine, Howard A.
    Kim, Lyndon
    Albert, Paul S.
    Duic, J. Paul
    Ma, Hilary
    Zhang, Wei
    Tohnya, Tanyifor
    Figg, William D.
    Royce, Cheryl
    CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7101 - 7106
  • [50] Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma
    Nayak, Lakshmi
    Abrey, Lauren E.
    Drappatz, Jan
    Gilbert, Mark R.
    Reardon, David A.
    Wen, Patrick Y.
    Prados, Michael
    Deangelis, Lisa M.
    Omuro, Antonio
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 58 - 61
12345